Vitiligo Trial, Recruiting (NCT07136467)

Vitiligo Trial, Recruiting NCT07136467 Sponsor: AbbVie Condition: Vitiligo

Printed from Voxsanity (voxsanity.com.au) — NCT07136467 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Vitiligo

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been officially diagnosed by a doctor with one of the following skin conditions: non-segmental vitiligo (a condition causing patches of skin to lose colour), moderate to severe alopecia areata (a condition causing significant hair loss), or moderate to severe hidradenitis suppurativa (a condition causing painful lumps under the skin)
You are able to understand and complete the study questionnaires, and if you are a teenager, you can have a caregiver help you with this

Who may not be able to join:

You are currently taking part in another clinical trial that involves a treatment or intervention (note: being part of a registry or observational study does not count and would not stop you from joining)
You are unwilling or unable to follow the study requirements and complete the required questionnaires about how you are feeling and your symptoms

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: ABBVIE INC., AbbVie

Phone: 844-663-3742

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07136467

Sponsor: AbbVie

Phase: Not Applicable

Status: Recruiting

Condition: Vitiligo

Trial contact: 844-663-3742

More information: https://clinicaltrials.gov/study/NCT07136467

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been officially diagnosed by a doctor with one of the following skin conditions: non-segmental vitiligo (a condition causing patches of skin to lose colour), moderate to severe alopecia areata (a condition causing significant hair loss), or moderate to severe hidradenitis suppurativa (a condition causing painful lumps under the skin)
You are able to understand and complete the study questionnaires, and if you are a teenager, you can have a caregiver help you with this

Who may not be able to join:

You are currently taking part in another clinical trial that involves a treatment or intervention (note: being part of a registry or observational study does not count and would not stop you from joining)
You are unwilling or unable to follow the study requirements and complete the required questionnaires about how you are feeling and your symptoms

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

AbbVie

Registry

ClinicalTrials.gov

Start date

2 September 2025

Est. completion

1 August 2027

Where this trial is recruiting

🇦🇷 Argentina 🇨🇦 Canada 🇨🇴 Colombia 🇨🇿 Czechia 🇪🇪 Estonia 🇫🇷 France 🇩🇪 Germany 🇬🇷 Greece 🇮🇹 Italy 🇯🇵 Japan 🇱🇻 Latvia Puerto Rico 🇷🇴 Romania 🇰🇷 South Korea 🇪🇸 Spain 🇨🇭 Switzerland 🇹🇼 Taiwan 🇬🇧 United Kingdom

Primary endpoints

Alopecia Areata (AA) symptoms affecting quality of life and daily functioning, assessed by the Alopecia Areata Symptom Impact Scale (AASIS) AA only; Measuring scalp hair loss, assessed by the Severity of Alopecia Tool (SALT) score. AA only; Measuring facial skin depigmentation, assessed by the Facial Vitiligo Area Scoring Index (F-VASI) Vitiligo Only; Vitiligo Quality of Life (QOL), assessed by Vitiligo Quality of Life Score (VitiQoL) Vitiligo Only; Hidradenitis Suppurativa (HS) Quality of Life (QOL), assessed by Dermatology Life Quality Index (DLQI)/Children's Dermatology Life Quality Index (...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov